Covadonga Pañeda
Direttore operativo presso ALTAMIRA THERAPEUTICS LTD.
Posizioni attive di Covadonga Pañeda
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALTAMIRA THERAPEUTICS LTD. | Direttore operativo | 01/01/2023 | - |
Corporate Officer/Principal | - | 01/01/2023 |
Storia della carriera di Covadonga Pañeda
Precedenti posizioni note di Covadonga Pañeda
Società | Posizione | Inizio | Fine |
---|---|---|---|
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Corporate Officer/Principal | 01/10/2020 | 01/04/2022 |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Direttore Tecnico/Scientifico/R&S | 01/03/2011 | 01/06/2018 |
Formazione di Covadonga Pañeda
Universidad Autónoma de Madrid | Doctorate Degree |
Statistiche
Distribuzione geografica
Spagna | 3 |
Bermuda | 2 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
Aziende private | 2 |
---|---|
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
- Borsa valori
- Insiders
- Covadonga Pañeda
- Esperienza